How is Cotempla XR-ODT different to other brands of methylphenidate?
Medically reviewed by Drugs.com Last updated on Sep 11, 2019.
Official Answerby Drugs.com
Cotempla XR-ODT is the first once-daily, extended-release, orally disintegrating tablet (ODT) formulation of the stimulant methylphenidate.
This ODT form is designed to dissolve on the tongue without the need to swallow with water.
Cotempla XR-ODT (methylphenidate) was approved in June 2017 for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age. It is not approved for use in adults.
Other brands of methylphenidate on the U.S market have various dosage forms.
For more information, see What are the brands of methylphenidate?
Related Medical Questions
- Ritalin vs Vyvanse - What's the difference between them?
- Concerta vs Adderall. What is the difference between them?
- What is the difference between Jornay PM and other once-daily methylphenidate formulations?
- What are the brands of methylphenidate?
- Adderall vs Vyvanse - What's the difference between them?
- Is QuilliChew ER a controlled substance?
- Is Dyanavel XR a controlled substance?